Fetal programming of metabolic disease - PowerPoint PPT Presentation

1 / 39
About This Presentation
Title:

Fetal programming of metabolic disease

Description:

Fetal programming of metabolic disease ... Caudal artery systolic BP [mmHg] 4. 8. Age [weeks] Control. Low Protein. Animal weights ... – PowerPoint PPT presentation

Number of Views:460
Avg rating:3.0/5.0
Slides: 40
Provided by: stevegr6
Category:

less

Transcript and Presenter's Notes

Title: Fetal programming of metabolic disease


1
Fetal programming of metabolic disease
  • A stimulus or insult at a critical period of
    early life, often when rates of growth are
    maximal, leads to irreversible changes in
    structure and function of target organs.
  • Pancreas ? Late onset diabetes
  • Kidney? ? Hypertension
  • Heart ? Coronary artery disease
  • Blood vessels ? Hypertension, atherosclerosis,
    stroke

Barker, DJ Clark, PM. (1997) Reviews of
Reproduction, 2 105-112.
2
Sheffield Ward
3
Relationship between fetal growth retardation and
blood pressure in middle age
Systolic (p 0.0005)
Diastolic (p 0.0001)
Blood PressuremmHg
Birth Weight kg
4
Relationship between fetal growth retardation and
arterial stiffness in middle age
PWV ms-1
Aorta (p 0.01)
-2.5
-3
-3.4
gt3.4
Birth Weight kg
Martyn CN et al. British Heart Journal, (1995).
73 116-121.
5
Babies
With thanks to Chris Martyn
6
What is the mechanism linking reduced birth
weight and increased blood pressure in adult life?
7
Hypothesis
  • With age, progressive fragmentation and loss of
    elastin (which cannot be resynthesised) and
    replacement by collagen --gt increased arterial
    stiffness --gt increased pulse pressure.
  • In growth retarded infants elastin synthesis is
    reduced in utero, arteries are stiffer than
    normal from an early age and never fully recover.

Martyn CN and Greenwald SE. Lancet. 1997 350
953-955.
8
Human aortic elastin collagen in early life
Protein ( dry weight)
50
40
30
Elastin
20
Collagen
10
Birth
0
Gestational age (weeks)
Months after birth
Berry CL, et al. (1972) Journal of Pathology.
108 265-274.
9
Normal
SUA
10
Compliance
Histology
UI present
Compliance /10 mmHg
UI absent
NORMAL
SUA ()
SUA (-)
Meyer WW and Lind J. (1974) Archives of Disease
in Childhood,. 49 671-679.
Berry CL et al. (1976) British Heart Journal, 38
310-315.
11
Twin to Twin Transfusion Syndrome (TTTS)
  • A natural model of the effects of volume loading
    on fetal vascular development.

12
TTTS occurs in identical twins
  • Most identical twins share a common placenta
    (monochorionic).
  • Of these, 10-15 develop TTTS wherein blood is
    unevenly distributed between them.
  • Thought to be due to the presence of deep
    arteriovenous anastomoses within the placenta.
  • Recipient
  • Hypervolaemia, polyuria, polyhydramnios, LV
    hypertrophy, systemic hypertension(?), cardiac
    malformations.
  • Donor
  • Hypovolaemia, poor renal perfusion, oliguria,
    oligohydramnios.

13
Prognosis treatment
  • Perinatal mortality in 80 to 100 of untreated
    cases
  • Amnioreduction (symptomatic)
  • to reduce amniotic fluid volume and pressure
  • 60 to 70 survival
  • Laser ablation of anastomoses
  • to prevent inter-twin transfusion and establish
    separate circulations
  • Better than 70 survival

14
Hypothesis
  • Previously shown that donor twin has 2x increase
    in brachial artery PWV in infancy
  • Is this due to chronic hypovolaemia and or
    abnormal pressure during uterine life?
  • If so, laser treatment, by restoring normal
    pressure and flow, should prevent vascular
    remodelling and reduce inter-twin PWV
    differences?

15
Subjects
  • 50 twin pairs (London Hamburg)
  • PWV measured in brachioradial artery
  • Median corrected postnatal age 11.1 months
  • Range 1 week to 64 months
  • Ethical approval in both centres

16
4 groups
TTTS Symptomatically treated (n 14)
No TTTS (n 12)
TTTS laser treated (n 13)
No TTTS Non identical (n 11)
17
Variables measured
  • Brachial artery PWV
  • Birthweight
  • Gestational age
  • BP differences between twins
  • Age at diagnosis
  • Mean age at PWV measurement

18
PWV donor recipient pairs
PWV ms-1
Symp
Laser
Non TTTS
Non I
TTTS
No TTTS
19
PWV differences
Heavier - Lighter ms-1
2
1
0
-1
-2
Symp
Laser
No TTTS
Non I
identical
TTTS
No TTTS
20
Limitations
  • Milder manifestation of TTTS in conservatively
    treated group
  • Variable onset and duration of TTTS before
    treatment
  • Radial artery compliance may not reflect that of
    central arteries and LV load
  • Cross sectional measurements at different (young)
    ages, no idea yet of long term effects

21
Conclusions
  • Vascular programming seen in identical twins with
    TTTS
  • PWV discordancy altered but not abolished by
    intrauterine laser treatment, to resemble that
    seen in fraternal twins with separate uterine
    circulations

22
Hypothesis
  • With age, progressive fragmentation and loss of
    elastin (which cannot be resynthesised) and
    replacement by collagen --gt increased arterial
    stiffness --gt increased pulse pressure.
  • In growth retarded infants elastin synthesis is
    reduced in utero, arteries are stiffer than
    normal from an early age and never fully recover.

Martyn CN and Greenwald SE. Lancet. 1997 350
953-955.
23
Animal model of fetal growth retardation
  • Pregnant rats divided into two groups
  • Low protein (LP) group given 9 protein diet
  • Control group (C) given 18 protein diet,
    isocaloric
  • Offspring weaned at 4 weeks onto normal diet
  • Animals killed at 4, 8 and12 weeks
  • Measure
  • BP or Left ventricular dimensions
  • Aortic elasticity chemical composition

Unpublished data
24
Left ventricle

25
Animal weights
26
Aortic Dimensions

Wall cross sectional area mm2

27
Aortic stiffness

Einc at ?? 1.3 kPa

28
Aortic elastin collagen
29
Conclusions
  • Reduced body weight, aortic dimensions, elastin
    content and increased BP or LV hypertrophy in 4
    12 week LP animals is consistent with the
    hypothesis that protein deprivation in utero
    leads changes in vessel structure and
    composition.
  • The elasticity differences in 4 and 12 week
    animals were consistent with the hypothesis.
    However the results from the 8 week animals are
    not.

30
Limitations
  • Preliminary study, limited age range
  • Lack of in vivo central pressure measurements.
  • Applicability of rat model to human in utero
    growth retardation?

31
Problem
  • Is the reduction in aortic elastin content a
    cause or a consequence of hypertension?

32
Skin stretch for 500 mbar. 60 children aged 10
-11y
Aortic stiffness (arbitrary units)
5.0
4.5
4.0
Plt0.01
3.5
3.0
2.5
Max stretch (mm)
33
  • Why do large arteries get stiffer with age?
  • Fatigue failure of irreplaceable elastin
  • (and atherosclerosis)
  • What are the consequences?
  • Increased pulse pressure
  • Increased peak load on the heart and conduit
    arteries
  • (and premature failure?)

34
Fingerprints and hypertension
35
Palmar angle
a
c
b
Palmar angle abc
36
3 basic types of fingerprint pattern
From Holt S. Quantitative genetics of
fingerprint patterns. Br. Med. Bull. 1961 17247
37
Fingerprint results
ATD angle ()
gt43
Systolic BP
No. of whorls on right hand
38
Fingerprint Summary
  • Blood pressure in middle age is strongly
    correlated with number of finger whorls
  • Inversely correlated with palmar angle

Godfrey et al. BMJ 307, 405-409 (1993)
39
Death By Old Age
Case Sex Age Occupation Findings
1 F 101 Laundress Cardiac hypertrophy and degeneration. Severe generalized arteriosclerosis
2 F 101 University professor Bronchopneumonia, influenza, cardiac hypertrophy, coronary sclerosis
3 M 102 Rabbi Cardiac hypertrophy, fibrosis, generalized arteriosclerosis
4 M 102 Restaurant owner Cardiac hypertrophy, fibrosis, coronaryvalvular sclerosis
5 M 106 Shepherd Bronchopneumonia, cardiac hypertrophy, fibrosis, fibrinous pericarditis, coronary sclerosis
2 F 101 University professor Bronchopneumonia, influenza, cardiac hypertrophy, coronary sclerosis
3 M 102 Rabbi Cardiac hypertrophy, fibrosis, generalized arteriosclerosis
4 M 102 Restaurant owner Cardiac hypertrophy, fibrosis, coronaryvalvular sclerosis
Robert L. Exp Gerontol 1999, 34491-501.
40
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com